Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by Teacher Retirement System of Texas

Teacher Retirement System of Texas lifted its position in Doximity, Inc. (NASDAQ:DOCS) by 62.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 113,025 shares of the company’s stock after acquiring an additional 43,531 shares during the period. Teacher Retirement System of Texas’ holdings in Doximity were worth $6,034,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Harvest Fund Management Co. Ltd boosted its stake in Doximity by 198.1% during the 4th quarter. Harvest Fund Management Co. Ltd now owns 26,889 shares of the company’s stock worth $1,435,000 after purchasing an additional 17,869 shares during the last quarter. Xponance Inc. lifted its stake in shares of Doximity by 9.2% in the fourth quarter. Xponance Inc. now owns 15,307 shares of the company’s stock worth $817,000 after buying an additional 1,291 shares in the last quarter. Thrivent Financial for Lutherans boosted its position in Doximity by 31.0% during the fourth quarter. Thrivent Financial for Lutherans now owns 40,609 shares of the company’s stock worth $2,169,000 after acquiring an additional 9,618 shares during the last quarter. Counterpoint Mutual Funds LLC purchased a new stake in Doximity during the 4th quarter valued at about $1,820,000. Finally, Corient Private Wealth LLC raised its holdings in Doximity by 3.9% in the 4th quarter. Corient Private Wealth LLC now owns 8,887 shares of the company’s stock valued at $474,000 after acquiring an additional 334 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Trading Up 0.4 %

DOCS stock opened at $63.01 on Monday. The business’s fifty day moving average price is $64.42 and its 200 day moving average price is $53.63. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21. The company has a market capitalization of $11.76 billion, a PE ratio of 63.01, a P/E/G ratio of 4.10 and a beta of 1.34.

Insiders Place Their Bets

In other news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 37.40% of the company’s stock.

Wall Street Analyst Weigh In

DOCS has been the topic of several recent research reports. The Goldman Sachs Group boosted their target price on Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Wells Fargo & Company restated an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. Leerink Partners raised Doximity from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $60.00 to $90.00 in a research note on Friday, February 7th. Raymond James reissued an “outperform” rating and set a $83.00 price target (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Finally, Piper Sandler upgraded shares of Doximity from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Doximity currently has an average rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.